Generate Biomedicines

Generate BiomedicinesGenerate Biomedicines
Generate Biomedicines

Generate Biomedicines

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

DR 522018Active330Somerville, United States
Rate

About

Generate Biomedicines is a clinical-stage biotherapeutics company that pioneers generative biology, integrating machine learning, biological engineering, and medicine to create novel protein therapeutics. Their platform, The Generate Platform, enables the on-demand generation of medicines across multiple modalities, aiming to revolutionize drug discovery and development by increasing speed, precision, and probability of success.

Technology stack

detected 2026-07-15
Email
gateway-fronted
Hosting
Analytics
Cookie consent
HEADCOUNT
330
DOMAIN RATING
52
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Generate Biomedicines do?

Generate Biomedicines is a clinical-stage biotherapeutics company that pioneers generative biology, integrating machine learning, biological engineering, and medicine to create novel protein therapeutics. Their platform, The Generate Platform, enables the on-demand generation of medicines across multiple modalities, aiming to revolutionize drug discovery and development by increasing speed, precision, and probability of success.

Where is Generate Biomedicines headquartered?

Generate Biomedicines is headquartered in Somerville, United States.

When was Generate Biomedicines founded?

Generate Biomedicines was founded in 2018.

What industry does Generate Biomedicines operate in?

Generate Biomedicines operates in Biotechnology, Drug Discovery, HealthTech, Life Sciences, Artificial Intelligence & Machine Learning, Biotech.

How many employees does Generate Biomedicines have?

Generate Biomedicines has approximately 330 people on record.

What is Generate Biomedicines's revenue?

StartupHub estimates Generate Biomedicines's annual revenue at $37.1M (range $19.5M to $109.8M, 70% confidence), based on comparable companies in the sector.

What is Generate Biomedicines's valuation?

StartupHub estimates Generate Biomedicines's effective valuation at $2.3B (range $1.6B to $3.0B, 43% confidence), based on comparable companies in the sector.